AB 16. Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer

BACKGROUND: To evaluate the effect of immunotherapy on response, survival and certain immunologic markers in SCLC patients receiving chemotherapy. PATIENTS AND METHODS: A total of 191 SCLC patients assigned to receive either chemotherapy alone (group A) or combination of chemotherapy and immunothera...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Zarogoulidis, Konstantinos, Ziogas, Eleftherios, Boutsikou, Efthimia, Zarogoulidis, Paul, Porpodis, Konstantinos, Latsios, Dimitris, Eleftheriadou, Ellada, Xatzizisi, Ourania, Kiriazis, Georgios
Médium: Artigo
Jazyk:Inglês
Vydáno: Pioneer Bioscience Publishing Company 2012
Témata:
Abstract
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3537413/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2012.s016
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky